• Single-Use Technologies (SUT) in Biosimilar Production

  • 著者： DD ENTERPRISES
  • ポッドキャスト

Single-Use Technologies (SUT) in Biosimilar Production

著者： DD ENTERPRISES
無料で聴く

  • サマリー

  • Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood

    and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which

    have a well-defined structure, biopharmaceuticals derive from living materials (human, animal,

    microorganism, or plant) and are much larger and more complex in structure. Because

    biopharmaceuticals work with the immune system and do not contain chemical-based drugs, there is

    a rapidly expanding acceptance of biopharmaceuticals to treat a range of diseases, and the market is

    growing quickly. The biopharmaceutical method of making drugs is an especially high-profile topic due

    to the global COVID-19 pandemic and the use of the mRNA vaccine, which is made using the

    biopharmaceutical process.

    Visit Site>> https://www.ddentp.com/

    Copyright 2024 DD ENTERPRISES
    続きを読む 一部表示

あらすじ・解説

Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood

and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which

have a well-defined structure, biopharmaceuticals derive from living materials (human, animal,

microorganism, or plant) and are much larger and more complex in structure. Because

biopharmaceuticals work with the immune system and do not contain chemical-based drugs, there is

a rapidly expanding acceptance of biopharmaceuticals to treat a range of diseases, and the market is

growing quickly. The biopharmaceutical method of making drugs is an especially high-profile topic due

to the global COVID-19 pandemic and the use of the mRNA vaccine, which is made using the

biopharmaceutical process.

Visit Site>> https://www.ddentp.com/

Copyright 2024 DD ENTERPRISES
科学 経済学
続きを読む 一部表示
エピソード
  • Episode 1

    Episode 1
    2024/09/17

    Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood

    and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which

    have a well-defined structure, biopharmaceuticals derive from living materials (human, animal,

    microorganism, or plant) and are much larger and more complex in structure. Because

    biopharmaceuticals work with the immune system and do not contain chemical-based drugs, there is

    a rapidly expanding acceptance of biopharmaceuticals to treat a range of diseases, and the market is

    growing quickly. The biopharmaceutical method of making drugs is an especially high-profile topic due

    to the global COVID-19 pandemic and the use of the mRNA vaccine, which is made using the

    biopharmaceutical process. Visit Site>> Click Here
    続きを読む 一部表示
    22 分

Single-Use Technologies (SUT) in Biosimilar Productionに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。